| Dataset | DrugBank Drug Targets |
| Category | physical interactions |
| Type | drug |
| Description | A C-glycosyl compound that is used (in its hemihydrate form) for treatment of type II diabetes via inhibition of sodium-glucose transport protein subtype 2. (Chemical Entities of Biological Interest Ontology, CHEBI_73274) |
| External Link | http://www.drugbank.ca/drugs/DB08907 |
| Similar Terms | |
| Downloads & Tools |
6 interacting proteins for the Canagliflozin drug from the curated DrugBank Drug Targets dataset.
| Symbol | Name |
|---|---|
| ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
| ORM1 | orosomucoid 1 |
| SLC5A1 | solute carrier family 5 (sodium/glucose cotransporter), member 1 |
| SLC5A2 | solute carrier family 5 (sodium/glucose cotransporter), member 2 |
| UGT1A9 | UDP glucuronosyltransferase 1 family, polypeptide A9 |
| UGT2B4 | UDP glucuronosyltransferase 2 family, polypeptide B4 |
